Literature DB >> 1101386

Intravenous ketamine for postoperative analgesia.

L Clausen, D M Sinclair, C H Van Hasselt.   

Abstract

Thirty-six consecutive patients who had undergone major surgery were carefully studied for 6 hours postoperatively in an attempt to evaluate the relative analgesic and respiratory-depressant effect of morphine, ketamine, and placebo administered by continuous intravenous infusion. Side-effects, vital signs and respiratory measurements were recorded hourly by a consultant physician. With regard to the dosage and method of administration, ketamine was shown to be less effective than morphine for the first 3 hours postoperatively, but equally effective subsequently, whereas the patients who received ketamine showed a greater progressive tendency for their respiratory parameters to improve with time. Recommendations regarding the postoperative control of pain are made, and the need for further study is noted.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1101386

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

1.  Subcutaneous ketamine analgesia: postoperative analgesia using subcutaneous infusions of ketamine and morphine.

Authors:  A Bristow; C Orlikowski
Journal:  Ann R Coll Surg Engl       Date:  1989-01       Impact factor: 1.891

2.  [Application procedures and dosage recommendations for postoperative analgesia.].

Authors:  W Dick; R Janik
Journal:  Schmerz       Date:  1988-03       Impact factor: 1.107

3.  Perioperative intravenous ketamine for acute postoperative pain in adults.

Authors:  Elina Cv Brinck; Elina Tiippana; Michael Heesen; Rae Frances Bell; Sebastian Straube; R Andrew Moore; Vesa Kontinen
Journal:  Cochrane Database Syst Rev       Date:  2018-12-20

4.  Investigation of the potentiation of the analgesic effects of fentanyl by ketamine in humans: a double-blinded, randomised, placebo controlled, crossover study of experimental pain[ISRCTN83088383].

Authors:  Adam P Tucker; Yong Ik Kim; Raymond Nadeson; Colin S Goodchild
Journal:  BMC Anesthesiol       Date:  2005-04-02       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.